US Patent Issued to CHIESI FARMACEUTICI on Oct. 27 for "Amino quinazoline derivatives as P2X3 inhibitors" (Italian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,277, issued on Oct. 27, was assigned to CHIESI FARMACEUTICI S.p.A. (Parma, Italy).

"Amino quinazoline derivatives as P2X3 inhibitors" was invented by Claudio Fiorelli (Parma, Italy), Paolo Bruno (Parma, Italy), Matteo Biagetti (Parma, Italy), Daniela Pizzirani (Parma, Italy), Daniele Pala (Parma, Italy), Paolo Ronchi (Parma, Italy), Sara Guariento (Parma, Italy), Charles Baker-Glenn (Parma, Italy), Herve Van De Poel (Parma, Italy) and Kim Louise Hirst (Parma, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula I inhibiting P2X purinoceptor 3; particularly the invention relates to compounds that ...